OnabotulinumtoxinA Injections for the Treatment of Cyclic Vomiting Syndrome

Publisher： John Wiley & Sons Inc

E-ISSN： 1875-9114|35|5|e51-e55

ISSN： 0277-0008

Source： PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY, Vol.35, Iss.5, 2015-05, pp. : e51-e55

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of Chronic Migraine with Intramuscular Pericranial Injections of Onabotulinumtoxin A

By  

Recent Patents on CNS Drug Discovery, Vol. 9, Iss. 3, 2014-12 ,pp. : 181-192

Bentham Science Publishers

Access to resources Recommend Favorite

Submucosal Administration of OnabotulinumtoxinA in the Treatment of Neurogenic Detrusor Overactivity: Pilot Single-Centre Experience and Comparison with Standard Injection into the Detrusor

By  

Urologia Internationalis, Vol. 91, Iss. 4, 2013-06 ,pp. : 423-428

Karger

Access to resources Recommend Favorite

Comparative trial of a novel botulinum neurotoxin type A versus onabotulinumtoxinA in the treatment of glabellar lines: A multicenter, randomized, double‐blind, active‐controlled study

By  

INTERNATIONAL JOURNAL OF DERMATOLOGY, Vol. 54, Iss. 2, 2015-02 ,pp. : 227-234

John Wiley & Sons Inc

Access to resources Recommend Favorite

NextGen nuclear DNA sequencing in cyclic vomiting syndrome reveals a significant association with the stress‐induced calcium channel (RYR2)

By  

NEUROGASTROENTEROLOGY & MOTILITY (ELECTRONIC), Vol. 27, Iss. 7, 2015-07 ,pp. : 990-996

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cyclic Vomiting Presentations Following Marijuana Liberalization in Colorado

By  

ACADEMIC EMERGENCY MEDICINE, Vol. 22, Iss. 6, 2015-06 ,pp. : 694-699

John Wiley & Sons Inc

Access to resources Recommend Favorite